Anthony Fauci on Covid-19 reopenings, vaccines, and ‘warp speed’
In an interview, the director of the National Institute for Allergy and Infectious Diseases expressed optimism on some fronts, and concern on others.
In an interview, the director of the National Institute for Allergy and Infectious Diseases expressed optimism on some fronts, and concern on others.
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
In this special episode of Healthcare Unfiltered, I delve into the realm of AI and its transformative impact on drug development with Adam Petrich, MD,…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Show Healthcare Unfiltered, Ep AI and Drug Development With Adam Petrich – Apr 23, 2024
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as…
Show Healthcare Unfiltered, Ep The ABIM-MOC Saga Continues – Apr 16, 2024